Patents by Inventor Pierre Renard

Pierre Renard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6605632
    Abstract: The invention concerns compounds of formula (I): R—A—R′ wherein: A is as defined in the description; R represents a group (V), (VI), (VII) or (VIII), where E, Q, R1, R2, R3, v and R4 are as defined in the description; R′ represents a —(CH2)t—R5 group wherein t and R5 are as defined in the description
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: August 12, 2003
    Assignee: Les Laboratoires Servier
    Inventors: Daniel Lesieur, Frédérique Klupsch, Gérald Guillaumet, Marie-Claude Viaud, Michel Langlois, Caroline Bennejean, Pierre Renard, Philippe Delagrange
  • Patent number: 6602903
    Abstract: The invention relates to compounds of formula (I): and medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
    Type: Grant
    Filed: August 28, 2001
    Date of Patent: August 5, 2003
    Assignee: Les Laboratories Servier
    Inventors: Gérald Guillaumet, Marie-Claude Viaud, Ahmed Mamai, Isabelle Charton, Pierre Renard, Caroline Bennejean, Béatrice Guardiola, Philippe Daubos
  • Publication number: 20030139408
    Abstract: The invention relates to a compound of formula (I): 1
    Type: Application
    Filed: November 27, 2002
    Publication date: July 24, 2003
    Inventors: Otto Meth-Cohn, Chu-Yi Yu, Pierre Lestage, Marie-Cecile Lebrun, Daniel-Henri Caignard, Pierre Renard
  • Publication number: 20030134847
    Abstract: The invention relates to compound of formula (I): 1
    Type: Application
    Filed: October 9, 2002
    Publication date: July 17, 2003
    Inventors: Gerald Guillaumet, Marie-Claude Viaud, Herve Van De Poel, Philippe Delagrange, Caroline Bennejean, Pierre Renard
  • Patent number: 6583319
    Abstract: The invention relates to compounds of for a (I): wherein: R represents ORa, SRa or Ra or a cyclic group A is a cyclic structure G1 and G2 represent an alkylene chain or a single bond B represents —NR1aC(Q)R2a, —NR1aC(Q)NR2aR3a or C(Q)NR1aR2a p and q are such that 1≦p+q≦4, and medicinal products containing the same which are useful in treating or in preventing melatoninergic disorders.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: June 24, 2003
    Assignee: Les Laboratoires Servier
    Inventors: Michel Langlois, Monique Mathe-Allainmat, Marie Lefas-Le Gall, Caroline Bennejean, Pierre Renard, Philippe Delagrange
  • Publication number: 20030105087
    Abstract: The invention relates to compound of formula (I): 1
    Type: Application
    Filed: October 9, 2002
    Publication date: June 5, 2003
    Inventors: Gerald Guillaumet, Marie-Claude Viaud, Herve Van De Poel, Philippe Delagrange, Caroline Bennejean, Pierre Renard
  • Patent number: 6569858
    Abstract: A compound selected from those of formula (I): wherein: R1 and R2, which may be identical or different, represent a group of formula U-V wherein U represents single bond, or alkylene which is optionally substituted and/or unsaturated, and V is as defined in the description, G represents oxygen, or NR3 wherein R3 is as defined in the description, X represents hydrogen, hydroxy, alkoxy, mercapto or alkylthio, Y represents hydrogen, or X+Y represents carbonyl, X1 represents hydrogen, hydroxy, alkoxy, mercapto or alkylthio, Y1 represents hydrogen, or X1+Y1 represents carbonyl, R4, R5, and R6 are as defined in the description, its isomers, and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same are useful in the treatment of cancer.
    Type: Grant
    Filed: November 5, 2001
    Date of Patent: May 27, 2003
    Assignee: Les Laboratoires Servier
    Inventors: Michelle Prudhomme, Pascale Moreau, Fabrice Anizon, Christelle Marminon, Ghanem Atassi, Alain Pierre, Bruno Pfeiffer, Pierre Renard
  • Publication number: 20030073841
    Abstract: A compound selected from those of formula (I): 1
    Type: Application
    Filed: July 25, 2002
    Publication date: April 17, 2003
    Inventors: Michel Koch, Francois Tillequin, Sylvie Michel, Elisabeth Seguin, Abdelhakim El Omri, John Hickman, Alain Pierre, Bruno Pfeiffer, Pierre Renard
  • Patent number: 6548515
    Abstract: The invention relates to compound of formula (I): wherein: represents a single or double bond, R0 represents hydrogen or hydroxy or alkoxy, R1 and R2, which are identical or different, each represents hydrogen or halogen or alkyl, alkoxy, hydroxy, polyhaloalkyl, nitro or optionally substituted amino or  wherein m represents an integer such that 1≦m≦4, or form together with the carbon atoms carrying them an aromatic or non-aromatic, mono- or bi-cyclic group having from 5 to 12 ring members and optionally containing 1 or 2 hetero atoms selected from O, S and N, R3 represents hydrogen or aryl, heteroaryl, cycloalkyl, optionally substituted alkyl or a group of formula COR7 wherein R7 represents aryl, optionally substituted alkyl, optionally substituted amino or OR10 wherein R10 represents aryl or optionally substituted alkyl, X represents oxygen or sulphur or —CH2— or —CH2—CH2—, Ar represents aryl, heteroaryl or arylalkyl, its op
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: April 15, 2003
    Assignee: Les Laboratories Servier
    Inventors: Henri-Philippe Husson, Sylviane Giorgi-Renault, Christophe Tratrat, Ghanem Atassi, Alain Pierre, Pierre Renard, Bruno Pfeiffer
  • Publication number: 20030055086
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: August 12, 2002
    Publication date: March 20, 2003
    Inventors: Bernard P. Roques, Marie-Claude Fournie-Zaluski, Nicolas Inguimbert, Herve Poras, Elizabeth Scalbert, Caroline Bennejean, Pierre Renard
  • Patent number: 6531232
    Abstract: The invention relates to a system comprising a first substrate (100) with at least one bonding area (110a, 110b), liable to be assembled with a second substrate (200), the bonding area (110a, 110b) comprising an area made of a material (104) that can be wetted with a meltable material. According to the invention, the bonding area (110a, 110b) comprises at least one cavity (120) to receive meltable material.
    Type: Grant
    Filed: April 16, 2001
    Date of Patent: March 11, 2003
    Assignee: Commissariat a l'Energie Atomique
    Inventors: François Baleras, Pierre Renard
  • Publication number: 20030040533
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: August 2, 2002
    Publication date: February 27, 2003
    Inventors: Daniel Lesieur, Elodie Blanc-Delmas, Said Yous, Patrick Depreux, Gerald Guillaumet, Catherine Dacquet, Nigel Levens, Jean Albert Boutin, Caroline Bennejean, Pierre Renard
  • Patent number: 6511992
    Abstract: The invention relates to a compound of formula (I): wherein: A represents pyridine, pyridinium or piperidine R1, R2, R3 and R4 are as defined in the description R5 represents hydrogen, a nitrogen-containing heterocycle or a group of formula (II) R6 represents hydrogen or linear or branched (C1-C6)alkyl; and medicinal products containing the same which are useful in treating pain or deficiencies in memory.
    Type: Grant
    Filed: September 25, 2001
    Date of Patent: January 28, 2003
    Assignee: les Laboratories Servier
    Inventors: Otto Meth-Cohn, Chu-Yi Yu, Pierre Lestage, Marie-Cécile Lebrun, Daniel-Henri Caignard, Pierre Renard
  • Publication number: 20030013742
    Abstract: Compound of formula (I): 1
    Type: Application
    Filed: June 21, 2002
    Publication date: January 16, 2003
    Inventors: Muriel Duflos, Jean-Michel Robert, Marie-Renee Nourrisson, Guillaume Le Baut, Daniel-Henri Caignard, Jean-Guy Bizot-Espiard, Pierre Renard
  • Patent number: 6503919
    Abstract: A compound selected from those of formula (I): wherein: X and Y represent hydrogen, halogen, hydroxy, mercapto, cyano, nitro, alkyl, alkoxy, trihaloalkyl, optionally substituted amino, methylenedioxy, or ethylenedioxy, R1 represents hydrogen, or alkyl, R2 represents hydrogen, hydroxy, alkyl, alkoxy, alkylcarbonyloxy, or optionally substituted amino, R3 and R4 represent hydrogen, or alkyl, R5 and R6 represent —O—CO—U—V wherein U and V are as defined in the description, or Z as defined in the description, it being understood that at least one of the R5 and R6 groups represents —O—CO—U—V, their isomers, N-oxides, and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same which are useful in the treatment of cancer.
    Type: Grant
    Filed: June 15, 2000
    Date of Patent: January 7, 2003
    Assignee: Les Laboratoires Server
    Inventors: Michel Koch, François Tillequin, Sylvie Michel, Ghanem Atassi, Alain Pierre, Pierre Renard, Bruno Pfeiffer
  • Patent number: 6495543
    Abstract: The invention relates to compounds of formula (I): wherein: G1 represents an alkylene chain as defined in the description, A represents R2 and R3 represent hydrogen, alkyl, alkoxy or hydroxy or together form oxo, R4 and R5 represent hydrogen or together form aryl, R1 is as defined in the description. and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: December 17, 2002
    Assignee: Les Laboratoires Servier
    Inventors: Gérald Guillaumet, Marie-Claude Viaud, Hervé Van De Poel, Philippe Delagrange, Caroline Bennejean, Pierre Renard
  • Patent number: 6451789
    Abstract: Compound of formula (I): wherein: n represents 0 or 1, R1 represents hydrogen, arylalkyl, alkyl, acyl, alkoxycarbonyl, arylalkoxycarbonyl or trifluoroacetyl, R2 represents alkyl, X represents oxygen, chlorine, OR3, SR4 or NOR5, R3 represents hydrogen , alkyl, acyl, alkoxycarbonyl or arylalkoxycarbonyl, R4 represents hydrogen, alkyl or aryl, R5 represents hydrogen or optionally substituted alkyl, represents a single or double bond, Ar represents aryl or heteroaryl, its isomers and addition salts thereof with a pharmaceutically acceptable acid, and medicinal products containing the same which are useful as facilitators of memory and cognition and antalgic agents.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: September 17, 2002
    Assignee: Les Labortoires Servier
    Inventors: Sylvain Rault, Olivier Renault, Jean Guillon, Patrick Dallemagne, Pierre Renard, Bruno Pfeiffer, Pierre Lestage, Marie-Cécile Lebrun
  • Patent number: 6423870
    Abstract: The invention concerns compounds of formula (I) in which: A forms a tricyclic system of formula A1, A2, A3 or A4; R1 represents a hydrogen atom, an alkyl, hydroxy, alkoxy or oxo group; (R2)m and (R3)m′ are such as defined in the description; n represents an integer such that 0≦n≦3; p represents an integer such as defined in the description; B represents a group (a) or (b). The invention is useful for preparing medicines.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: July 23, 2002
    Assignee: Les Laboratoires Servier
    Inventors: Michel Langlois, Monique Mathe-Allainmat, Carole Jellimann, Jean Andrieux, Caroline Bennejean, Pierre Renard, Philippe Delagrange
  • Publication number: 20020055510
    Abstract: A compound selected from those of formula (I): 1
    Type: Application
    Filed: November 5, 2001
    Publication date: May 9, 2002
    Inventors: Michelle Prudhomme, Pascale Moreau, Fabrice Anizon, Christelle Marminon, Ghanem Atassi, Alain Pierre, Bruno Pfeiffer, Pierre Renard
  • Publication number: 20020052400
    Abstract: The invention relates to compounds of formula (I): 1
    Type: Application
    Filed: August 28, 2001
    Publication date: May 2, 2002
    Applicant: ADIR ET COMPAGNIE
    Inventors: Gerald Guillaumet, Marie-Claude Viaud, Ahmed Mamai, Isabelle Charton, Pierre Renard, Caroline Bennejean, Beatrice Guardiola, Philippe Daubos